Chlorpheniramine / dextromethorphan / methscopolamine Pregnancy and Breastfeeding Warnings
Brand names: Extendryl DM
Chlorpheniramine / dextromethorphan / methscopolamine Pregnancy Warnings
Chlorpheniramine/DM/methscopolamine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/dextromethorphan/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
Chlorpheniramine / dextromethorphan / methscopolamine Breastfeeding Warnings
There are no data on the excretion of chlorpheniramine/DM/methscopolamine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2022) "Product Information. Extendryl DM (chlorpheniramine/DM/methscopolamine)." Apothecon Inc
References for breastfeeding information
- (2022) "Product Information. Extendryl DM (chlorpheniramine/DM/methscopolamine)." Apothecon Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
